Certara, Inc. (NASDAQ:CERT) Q1 2023 Results Conference Call May 8, 2023 5:00 PM ET

Company Participants

David Deuchler - Investor Relations

William Feehery - Chief Executive Officer

John Gallagher - Chief Financial Officer

Conference Call Participants

David Windley - Jefferies

Vikram Purohit - Morgan Stanley

Jeff Garro - Stephens Inc.

Luke Sergott - Barclays

Max Smock - William Blair

Wolf Chanoff - Bank of America

Joy Zhang - SVB Securities

Gaurav Goparaju - Berenberg Capital Markets

Joe Vruwink - Baird

Operator

Good day, and thank you for standing by. Welcome to the Certara First Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to your speaker today, David Deuchler, Investor Relations. Please go ahead.

David Deuchler

Good afternoon, everyone. Thank you all for participating in today’s conference call. On the call from Certara, we have William Feehery, Chief Executive Officer; and John Gallagher, Chief Financial Officer. Earlier today, Certara released financial results for the quarter ended March 31, 2023. A copy of the press release is available on the Company’s website.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements, and actual results may differ materially from those expressed or implied in the forward-looking statements. Please refer to slide 2 in the accompanying materials for additional information, which you can find on the Company’s Investor Relations site.

In their remarks or responses to questions, management may mention some non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are available in the recent earnings release available on the Company’s website. For additional information, please refer to the reconciliation tables in the accompanying materials. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, May 8, 2023. Certara disclaims any obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.

And with that, I will turn the call over to William.

William Feehery

Thank you, David. Good afternoon, everyone. Thank you for joining Certara’s First Quarter 2023 Earnings Call. John and I will start with prepared remarks, and then we will take your questions.

We are pleased with our start to 2023, which positions us well for the remainder of this year and beyond. Our team is focused on executing Certara’s mission to accelerate medicines to patients using biosimulation, software and services. We continue to see expanded interest from customers looking to safely accelerate the drug development process through the use of biosimulation. We deliver information and analysis that informs critical decision-making that will lower the cost of development and increase the probability of success in clinical trials, ultimately improving the health and well-being of millions of people globally.